Quick Answer
Universe Pharmaceuticals INC reported Earnings Per Share Diluted of $8.06 (loss) per share for the year ending 2025.
- Universe Pharmaceuticals INC showed an increase of +98.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Universe Pharmaceuticals INC's annual report (Form 10-K), filed with the SEC on January 29, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Universe Pharmaceuticals INC's Earnings Per Share Diluted has declined by 1,814.9%.
- Historical annual values: Fiscal year 2025: $8.06 (loss) per share | Fiscal year 2024: $626.96 (loss) per share | Fiscal year 2023: $1,089.21 (loss) per share | Fiscal year 2022: $1,309.11 (loss) per share | Fiscal year 2021: $3.58 per share | Fiscal year 2020: $0.47 per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: